首页> 外文期刊>Therapeutic delivery >Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days
【24h】

Biodistribution of PLGA and PLGA/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days

机译:重复剂量口服递送F344大鼠7天后PLGA和PLGA /壳聚糖纳米颗粒的生物分布

获取原文
获取原文并翻译 | 示例
       

摘要

Aim: To quantify in vivo the biodistribution of poly(lactic-co-glycolic) acid (PLGA) and PLGA/chitosan nanoparticles (PLGA/Chi NPs) and assess if the positive charge of chitosan significantly enhances nanoparticle absorption in the GI tract.Material & methods: PLGA and PLGA/Chi NPs covalently linked to tetramethylrhodamine-5-isothiocyanate (TRITC) were orally administered to F344 rats for 7 days, and the biodistribution of fluorescent NPs was analyzed in different organs.Results: The highest amount of particles (% total dose/g) was detected for both treatments in the spleen, followed by intestine and kidney, and then by liver, lung, heart and brain, with no significant difference between PLGA and PLGA/Chi NPs.Conclusion: Only a small percentage of orally delivered NPs was detected in the analyzed organs. The positive charge conferred by chitosan was not sufficient to improve the absorption of the PLGA/Chi NPs over that of PLGA NPs.
机译:目的:为了量化体内聚乳酸-乙醇酸(PLGA)和PLGA /壳聚糖纳米颗粒(PLGA / Chi NPs)的生物分布并评估壳聚糖的正电荷是否显着增强了胃肠道中的纳米颗粒吸收。方法:对F344大鼠口服共7天与四甲基罗丹明5-异硫氰酸酯(TRITC)共价连接的PLGA和PLGA / Chi NPs,分析荧光NPs在不同器官中的生物分布。两种治疗方法均在脾脏中检测到总剂量(g /%),然后依次是肠和肾,然后检测到肝,肺,心脏和脑,但PLGA和PLGA / Chi NP之间无显着差异。在被分析的器官中检测到口服递送的NP的百分比。与PLGA NPs相比,壳聚糖赋予的正电荷不足以改善PLGA / Chi NPs的吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号